CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in FHTX — Foghorn Therapeutics Inc.
CIK 884546
SAN FRANCISCO, CA
Position in FHTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$535,731
+$40,882 QoQ
Shares Held
109,781
+6.0% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 102 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FHTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. FHTX ranks #256 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in FHTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $535,731 | 109,781 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $494,849 | 103,525 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $444,760 | 82,363 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $480,119 | 98,184 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $461,431 | 98,177 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $275,556 | 75,495 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $356,336 | 75,495 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $702,858 | 75,495 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $393,846 | 68,495 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $372,015 | 55,442 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $357,600 | 55,442 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $277,210 | 55,442 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $390,311 | 55,442 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $340,559 | 54,929 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $350,447 | 54,929 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $455,623 | 53,103 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $722,527 | 53,127 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $789,980 | 51,870 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,162,047 | 50,811 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $695,914 | 49,958 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $761,421 | 71,361 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $627,407 | 47,603 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $931,528 | 45,956 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||